Veradigm (MDRX) Hisse Fiyat
Veradigm Fiyat
Veradigm, son 20 yılda gelirini yıllık %9,2 artırarak 588,02 M USD seviyesine taşıdı. Hisse başına kâr, son 17 yılda yıllık %17,2 büyüdü. Veradigm için net marj, %-14,7 ile birkaç yıl önceki %-11,2 seviyesine göre geriledi. Veradigm için 12 aylık konsensüs fiyat hedefi 18,50 USD; bu, hissenin bugünkü fiyatının yaklaşık %270,0 üzerinde bir seviyeye denk geliyor. 7 analistten 6 tanesi hisse için alım öneriyor — genel konsensüs: Al.
Veradigm hisse senedi fiyatı
Bu verilere Eulerpool API üzerinden ulaşın
Ayda 100.000 ücretsiz istek · kredi kartı yok
Veradigm iş modeli ve hisse analizi
Veradigm hakkında sık sorulan sorular
Allscripts Healthcare Solutions Inc is a leading healthcare technology company that provides innovative solutions and services to healthcare organizations. The business model of Allscripts revolves around the development and provision of electronic health record (EHR) systems, practice management software, and other healthcare IT solutions. By offering integrated platforms, Allscripts enables healthcare providers to streamline operations, improve patient care, and enhance clinical outcomes. With a focus on promoting interoperability and connectivity, Allscripts facilitates efficient data exchange across healthcare settings. By leveraging technology and data analytics, Allscripts aims to optimize workflows, enhance decision-making processes, and ultimately improve the overall delivery of healthcare services.
Allscripts Healthcare Solutions Inc is primarily active in the healthcare industry.
The main competitors of Allscripts Healthcare Solutions Inc in the market include Cerner Corporation, Epic Systems Corporation, and Meditech.
Allscripts Healthcare Solutions Inc is a leading healthcare information technology company established in 1986. The company features a rich history and background, having grown from a small startup to a global provider of electronic health records (EHR), practice management systems, and population health management solutions. Allscripts is dedicated to enhancing patient care by empowering healthcare organizations with innovative technology. With a strong presence in the healthcare industry, Allscripts serves over 180,000 physicians and more than 2,500 hospitals worldwide. Continuously evolving and expanding its offerings, Allscripts Healthcare Solutions Inc remains at the forefront of the digital healthcare revolution.
Allscripts Healthcare Solutions Inc has achieved several significant milestones in its history. The company has successfully launched innovative products, expanded its market share, and entered into strategic partnerships within the healthcare industry. Allscripts Healthcare Solutions Inc has also received industry recognition for its excellent performance and dedication to providing high-quality healthcare solutions. By continuously investing in research and development, the company has consistently improved its technology offerings, contributing to the overall advancement of healthcare services. With its commitment to excellence, Allscripts Healthcare Solutions Inc continues to shape the future of healthcare with its groundbreaking solutions and services.
Allscripts Healthcare Solutions Inc is primarily present in the United States of America.
Allscripts Healthcare Solutions Inc represents the values of innovation, collaboration, and patient-centered care. With a commitment to improving healthcare technology, Allscripts aims to transform the way healthcare is delivered and experienced. The company values a collaborative approach, working closely with healthcare providers and patients to develop solutions that enhance clinical outcomes and patient satisfaction. Allscripts prioritizes the use of advanced technology and data analytics to drive better healthcare decision-making and deliver personalized care. Through its comprehensive suite of software and services, Allscripts aims to empower healthcare organizations to deliver efficient, high-quality care to their patients.
Analistler şu anda Veradigm hissesi için ortalama 16,17 USD hedef fiyat belirliyor (medyan: 18,50 USD); bu, son fiyata göre +223,4 % anlamına gelir. Konsensüs 7 analist notuna dayanır.
7 analist şu anda Veradigm hissesini değerlendiriyor: 6 al, 1 tut, 0 sat öneriyor.
Güncel döviz kuruyla Veradigm hissesi 4,48 EUR (5,00 USD) seviyesindedir.
Veradigm hissesi (MDRX) 4 borsada işlem görür, bunlar arasında: NASDAQ (MDRX), Frankfurt (AL21.F), München (AL21.MU), Düsseldorf (AL21.DU).
Allscripts Healthcare Solutions Inc is an American company specializing in providing IT solutions for healthcare providers. The company was founded in 1986 as a small software firm in Chicago and has since become one of the leading providers of electronic health records and other health IT solutions. Allscripts offers a wide range of products and services to meet the needs of healthcare providers of all sizes and types. The various business areas of Allscripts include hospitals and health systems, physician practices, accountable care organizations (ACOs), and pharmacies. Allscripts' products and services are designed to increase the efficiency of healthcare providers, improve the quality of patient care, and meet the growing demand for connected healthcare. In the hospital and health systems area, Allscripts offers a comprehensive portfolio of solutions to meet the complex requirements of large and complex health systems. This includes electronic health records, laboratory and imaging management, portfolio management, revenue cycle management, and reporting. In the physician practices area, Allscripts provides a variety of solutions to increase the efficiency of individual practices and smaller group practices. Products in this area include electronic health records, appointment scheduling, billing, prescription management, and patient portals. For ACOs, Allscripts offers a variety of solutions to support the community of healthcare facilities and providers. This includes solutions for collaboration management, population health management, and the automation of clinical workflows. Allscripts' solutions are also of interest to pharmacies. Allscripts offers solutions for optimizing inventory management, billing, and patient care. The company relies on state-of-the-art IT solutions and implements industry-leading methods for data analysis. Allscripts employs over 8,600 employees and has customers in over 190 countries. The company demonstrates its commitment to innovation in the healthcare industry through the development of new products and services. For example, a program to enhance the functionality of implanted pacemakers was recently introduced, which can be operated directly from a smartphone via a secure cloud system. With the introduction of new products and solutions, Allscripts aims to further expand its business in the healthcare sector and strengthen its position as a leading provider of health IT solutions. In summary, Allscripts Healthcare Solutions Inc is a leading provider of health IT solutions that offers a wide range of products and services for healthcare providers of all sizes and types. Allscripts aims to make healthcare more sustainable, digital, and connected, and to increase the efficiency of the healthcare system through innovative solutions.
Hasılat Veradigm için şu anda hesaplanamaz.
beklenen'nin Veradigm karı 32,67 M USD'dir. Net kar, tüm giderleri düştükten sonra şirketin kârlılığını gösterir.
Veradigm'nin Fiyat/Kazanç (F/K) oranı şu anda 19,73'dir. F/K oranı, cari hisse fiyatını hisse başına kazançla karşılaştırır ve yatırımcıların Veradigm hisse senedinin değerlemesini değerlendirmelerine yardımcı olur.
F/S Veradigm için şu anda hesaplanamaz.
Veradigm'nin Eulerpool Kalite Puanı 0/10'dur.
Veradigm'nin ISIN'i US01988P1084'dir. ISIN (Uluslararası Menkul Kıymetler Kimlik Numarası), menkul kıymetler için küresel olarak benzersiz bir tanımlayıcıdır.
Veradigm'nin WKN'i 607917'dir. WKN (Wertpapierkennnummer), menkul kıymetleri tanımlamak için kullanılan altı haneli bir Alman kimlik numarasıdır.
Veradigm'nin ticker'ı MDRX'dir. Ticker sembolü, Veradigm hisseleri borsada işlem görmek için kullanılır.
Veradigm Hissesi
Veradigm Emsaller Grubu
Veradigm Ticker
Veradigm FIGI
Veradigm'nin tüm temel göstergeleri ve derinlemesine analizi
Veradigm hissesine yönelik aktienanalizimiz, satış, kar, P/E oranı, P/S oranı, EBIT gibi önemli mali kriterleri içermekte olup, dividende bilgilerini de ele almaktadır. Ayrıca, hisseler, piyasa değeri, borçlar, özsermaye ve Veradigm şirketin yükümlülükleri gibi konuları incelemekteyiz. Bu konular hakkında daha detaylı bilgilere ihtiyacınız varsa, web sitemizin alt sayfalarında kapsamlı analizler sunuyoruz: